RGG0853

DB18669ExperimentalGene Therapies

RGG0853 is an E1A lipid complex, a repressor gene complexed with a cationic lipid vector.

Also known as
E1A gene therapy · HER-2/neu inhibitor · RGG0853, E1A lipid complex · tgDCC-E1A gene therapy
Code names
LF 160519 · RGG-0853

Which companies are running trials of RGG0853, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In